![Ran Nussbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ran Nussbaum
Directeur/Membre du Conseil chez
LB PHARMACEUTICALS INC
Fortune : 59 063 $ au 31/05/2026
Profil
Ran Nussbaum is the founder of Pontifax Management Co. Ltd., founded in 2004, serving as Managing Partner.
Mr. Nussbaum is the founder of Pontifax Group, founded in 2004, serving as Managing Partner.
Current jobs include Director at Pontifax Management 2 G.P.
(2007) Ltd., Pontifax (Israel) IV LP, Anaveon AG, Lutris Pharma Ltd., Indapta Therapeutics, Inc., Graviton Bioscience Corp., Orvida Pharma Ltd., and Advisory Committee member at Aliment Capital LLC.
Managing Partner at Pontifax Management 4 Gp 2015 Ltd. Independent Director at LB Pharmaceuticals, Inc. since 2023.
Former jobs include Chairman & Chief Executive Officer at BioMedix, Inc. from 2006 to 2008; Chief Executive Officer at Spearhead, LLC from 2009 to 2010; Chairman at SciSparc Ltd. from 2007 to 2010; Chairman at Spearhead Investments (Bio) Ltd.; Chairman at OCON Medical Ltd.; Director at ArQule, Inc., Bioblast Pharma Ltd., CollPlant Ltd., Nutrinia Ltd., Quiet Therapeutics Ltd., Eloxx Pharmaceuticals Ltd., Fore Biotherapeutics, Inc., N T B Pharma Ltd., Zolex Therapeutics Ltd., Pontifax (Cayman) III LP, Pontifax (Israel) III LP, and SciSparc Ltd. Director at ProtAb Ltd. from 2010 to 2014; Director at Erech Finance Cahalacha Ltd. from 2013 to 2015; Director at CollPlant Biotechnologies Ltd. from 2010 to 2014; Independent Director at Kite Pharma, Inc. from 2014 to 2017; Director at cCAM Biotherapeutics Ltd. from 2012 to 2015; Independent Director at UroGen Pharma Ltd. from 2013 to 2023; Director at Fusimab Ltd. from 2010 to 2014; Director at VBI Vaccines, Inc. from 2017 to 2018; Independent Director at Eloxx Pharmaceuticals, Inc. from 2017 to 2022; Independent Director at Prevail Therapeutics, Inc. from 2018 to 2021; Independent Director at Keros Therapeutics, Inc. from 2023 to 2025.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/10/2025 | 5 250 ( 0,03% ) | 59 063 $ | 31/05/2026 |
Postes actifs de Ran Nussbaum
| Sociétés | Poste | Début |
|---|---|---|
| LB PHARMACEUTICALS INC | Directeur/Membre du Conseil | 01/08/2023 |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions. | Fondateur | 01/01/2004 |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | - |
Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal | - |
Aliment Capital Llc
 Aliment Capital Llc Investment ManagersFinance Aliment Capital seeks investment opportunities in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early, later and growth stage capital requirements. | Consultant / Advisor | - |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Directeur/Membre du Conseil | - |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Directeur/Membre du Conseil | - |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Directeur/Membre du Conseil | - |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Ran Nussbaum
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
39
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 39 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
BioMedix, Inc.
 BioMedix, Inc. Medical SpecialtiesHealth Technology Provides equipment and services for non invasive detection of peripheral vascular disease | Health Technology |
Spearhead, LLC | |
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pontifax Management Co. Ltd.
Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions. | Finance |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology Specializes in the development and commercialization of medical products | Health Technology |
SciSparc Ltd.
 SciSparc Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative vaccines and immunotherapy products | Health Technology |
ProtAb Ltd.
 ProtAb Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents that modulate cytokine regulation and tipping the balance toward anti-inflammatory signaling pathways | Health Technology |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Develops bioactive feed supplements for infant formulas and animal feed | Health Technology |
Spearhead Investments (Bio) Ltd. | |
Erech Finance Cahalacha Ltd.
 Erech Finance Cahalacha Ltd. Medical SpecialtiesHealth Technology Engages in the research and development of insulin treatment methods | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets novel immunotherapy to treat cancer | Health Technology |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
OCON Medical Ltd.
 OCON Medical Ltd. Medical/Nursing ServicesHealth Services Develops an advanced intrauterine device | Health Services |
Fusimab Ltd. | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel genetic therapies | Health Technology |
Pontifax Group | |
Pontifax Management 2 G.P. (2007) Ltd. | |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Aliment Capital Llc
Aliment Capital Llc Investment ManagersFinance Aliment Capital seeks investment opportunities in companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early, later and growth stage capital requirements. | Finance |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
N T B Pharma Ltd.
 N T B Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Provides scientific and technical research development services | Commercial Services |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Zolex Therapeutics Ltd.
 Zolex Therapeutics Ltd. BiotechnologyHealth Technology Develops orally-active, small molecular weight antibiotics that tackling drug resistant bacterial infections | Health Technology |
Pontifax (Cayman) III LP
 Pontifax (Cayman) III LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Pontifax (Israel) III LP
 Pontifax (Israel) III LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Pontifax (Israel) IV LP
Pontifax (Israel) IV LP Financial ConglomeratesFinance Provides investment services | Finance |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Pontifax Management 4 Gp 2015 Ltd. | |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Develops biologics for cancer | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Kamari Pharma Ltd.
 Kamari Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company the develops inhibitors for the treatment of dermatological diseases | Health Technology |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary, off-the-shelf, allogeneic natural killer cell therapy to treat cancer | Health Technology |
Graviton Bioscience Corp.
Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Health Technology |
